Regulation of Gene Expression and Signaling Pathway Activity in Mammalian Cells by Automated Microfluidics Feedback Control by Postiglione, Lorena et al.
                          Postiglione, L., Napolitano, S., Pedone, E., Rocca, D., Aulicino, F.,
Santorelli, M., ... di Bernardo, D. (2018). Regulation of Gene Expression and
Signaling Pathway Activity in Mammalian Cells by Automated Microfluidics
Feedback Control. ACS Synthetic Biology, 7(11), 2558-2565.
https://doi.org/10.1021/acssynbio.8b00235
Peer reviewed version
Link to published version (if available):
10.1021/acssynbio.8b00235
Link to publication record in Explore Bristol Research
PDF-document
This is the author accepted manuscript (AAM). The final published version (version of record) is available online
via ACS at https://pubs.acs.org/doi/10.1021/acssynbio.8b00235 . Please refer to any applicable terms of use of
the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms
 1 
Regulation of gene expression and signaling pathway activity in mammalian 
cells by automated microfluidics feedback control. 
Lorena Postiglione1, Sara Napolitano1*, Elisa Pedone2,3,*, Daniel L. Rocca2,3,4,*, Francesco Aulicino4,5, 
Marco Santorelli1, Barbara Tumaini1, Lucia Marucci2,3,4#, Diego di Bernardo1,6# 
1 Telethon Institute of Genetics and Medicine, Via Campi Flegrei 34 80078 Pozzuoli (NA), Italy  
2Department of Engineering Mathematics, University of Bristol, Bristol BS8 1UB, UK  
3School of Cellular and Molecular Medicine, University of Bristol, Bristol BS8 1UB, UK 
4BrisSynBio, Bristol BS8 1TQ, UK 
5Department of Biochemistry, University of Bristol, Bristol BS8 1UB, UK 
6Department of Chemical,  Materials and Industrial Engineering, University of Naples Federico II, Piazzale 
V. Tecchio 80, 80125 Naples, Italy 
*These authors contribute equally to this work. 
#co-corresponding; dibernardo@tigem.it; lucia.marucci@bristol.ac.uk 
Keywords: Control Engineering, Microfluidics, Synthetic Biology 
Abstract 
Gene networks and signalling pathways display complex topologies and, as a result, complex non-
linear behaviours. Accumulating evidence shows that both static (concentration) and dynamical 
(rate-of-change) features of transcription factors, ligands and environmental stimuli control 
downstream processes and ultimately cellular functions. Currently, however, methods to generate 
stimuli with desired features to probe cell response are still lacking. Here, combining tools from 
Control Engineering and Synthetic Biology (Cybergenetics), we propose a simple and cost-effective 
microfluidics-based platform to precisely regulate gene expression and signalling pathway activity 
in mammalian cells by means of real-time feedback control. We show that this platform allows: (i) 
to automatically regulate gene expression from inducible promoters in different cell types, including 
mouse embryonic stem cells; (ii) to precisely regulate the activity of the mTOR signalling pathway 
in single cells; (iii) to build a bio-hybrid oscillator in single embryonic stem cells by interfacing 
biological parts with virtual in silico counterparts. Ultimately, this platform can be used to probe 
gene networks and signalling pathways to understand how they process static and dynamic features 
of specific stimuli, as well as for the rapid prototyping of synthetic circuits for biotechnology and 
biomedical purposes. 
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Mammalian cells are dynamical systems. They detect, adapt and respond to time-varying inputs 
such as environmental cues, secreted molecules, and mechanical stimuli. These processes are 
controlled by genes, proteins, small molecules, and their mutual interactions giving rise to gene 
networks and signalling pathways, often including positive and negative feedback loops. Such gene 
networks can exhibit nonlinear behaviours, such as multistability and oscillatory dynamics, with 
important consequences for cellular phenotypes. Despite their individual components being well 
characterised, operational understanding of how these regulatory networks work is still lacking1. 
Indeed, understanding how they process and respond to time-varying stimuli and ultimately modify 
cell behaviour will enable rational modification of cellular processes, an essential capability for 
biomedicine and biotechnology. Currently, however, it is very difficult, if not impossible in some 
cases, to apply stimuli with desired amplitudes and temporal dynamics, rather coarse stimuli are 
often used (i.e. gene over-expression, knock-down, adding or removing a ligand), thus preventing 
full exploration of network behaviour2,3. The nascent field of Cybergenetics explores how Control 
Engineering principles can be applied to dynamically steer biological processes at will4,5. 
Successful attempts to design control systems to dynamically regulate gene expression have been 
recently reported in the literature6, but mainly in prokaryotes and single-cell eukaryotes7–13. Control 
systems usually employ a negative feedback approach, where a control algorithm decides the 
amplitude and duration of the stimulus (e.g. small molecule, ligand, light) to apply to the cell to 
minimize the difference between the measured and the target fluorescence levels. Experimental 
control platforms have been implemented using both microfluidics and optogenetics approaches, 
with the latter reducing actuation time, but requiring significant genetic modification to cells in 
order to make them responsive to the light input. The application of control engineering to 
mammalian systems is still very limited.14 The reason for the slower progress can be attributed to 
different factors: increased experimental time and costs required to genetically engineer a 
mammalian cell, slower overall dynamics, and increased sensitivity to environmental conditions 
(e.g. phototoxicity, shear stress, etc.). All together these factors make the application of control 
engineering to mammlian cells much more challenging. We recently described a microfluidics 
platform enabling automatic regulation of gene expression from drug-inducible promoters in 
mammalian cells15. The experimental set-up (Figure 1a) consists of a microfluidic device hosted in 
an inverted fluorescence microscope and two syringes whose position is automatically controlled by 
stepper motors and connected to the device cell chambers in order to dynamically change the 
concentration of an inducer molecule10,11,15 16. Here, by means of a microfluidics-based platform, 
we make it possible to precisely and robustly control both gene expression and signalling pathway 
activity in mammalian cells of biotechnological and biomedical interest, including stem cells 
(Figure 1b). We also implement a bio-hybrid circuit combining biological parts with “virtual” in-
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silico parts in stem cells to speed up prototyping of biomolecular circuits for Synthetic Biology 
applications, with relevance to regenerative medicine17. 
Results 
Overview of the control platform.  A schematic representation of the experimental platform is 
shown in Figure 2a. A computer controls the whole platform by: (i) acquiring images at predefined 
time intervals; (ii) performing image analysis to quantify the phenotype of interest in cells, by 
means of fluorescent reporters, and the level of the inducer molecule in the device cell chambers, by 
means of a fluorescent dye; (iii) executing the biological system controller to compute the necessary 
amount and duration of inducer molecule treatment (control input) for the fluorescence to reach its 
target value (reference); (iv) executing the inducer molecule controller to move two motor-
controlled syringes to provide inducer molecule to the cells according to the control input 
(Supporting Information).  
Both the inducer molecule controller and the biological system controller follow the Model 
Predictive Control strategy (MPC), which has previously been applied to control biological systems 
but never in mammalian cells8,9,11,12 (Supporting Information). The MPC strategy is preferred to 
simpler input-output controllers (e.g. PID) as it naturally allows to include experimental constrains 
such as sampling time and bounded control input in the controller design. 
Two motor-controlled syringes, shown in Figure 2b, provide a (time-varying) concentration of an 
inducer molecule by mixing two fluids (medium with inducer plus fluorescent dye or standard 
medium). Figure 2c shows an example of an inducer molecule tracking control experiments 
(Supporting Information, Figure S6) where the concentration of tetracycline in the microfluidics 
cell chamber was automatically regulated by the inducer molecule controller to track a target time-
varying concentration (staircase and ramp).  
Control of gene expression in Chinese Hamster Ovary cells. We assessed the feasibility of 
precisely regulating the expression of a gene of interest from an inducible promoter by means of 
automated microfluidics feedback control. We stably integrated in Chinese Hamster Ovary (CHO) 
cells (Figure 1b) a tetracycline responsive promoter18 driving the expression of a fluorescent 
reporter protein (UbV76GFP) destabilised both at the mRNA and protein level19. These cells 
constitutively express the artificial tetracycline-responsive transcriptional activator tTA. When 
tetracycline is administered to the cells, tTA is not able to bind the promoter preventing expression 
of the fluorescent report (TET-OFF system). We used a destabilised mRNA, in addition to a 
destabilised protein, to maximally speed up system dynamics, as these are dictated by both mRNA 
and protein degradation rates.19 Indeed, in the absence of the mRNA degradation tag, the dynamics 
of the system are dominated by the UbV76GFP mRNA, whose half-life is about 130 min19, even 
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though the UbV76GFP protein half-life is just 20 min19. On the contrary, when the 3’UTR 
degradation tag was added, the mRNA half-life became 18 min19, thus considerably speeding up the 
system. In our previous proof-of-principle study15, we used a slower  degrading protein with an half 
life of 2 hours (d2YFP) with no mRNA destabilisation. The resulting system dynamics were much 
slower (Figure 3b in Fracassi et al15) causing the system to exhibit oscillation when using a PI 
controller. Moreover, in Supplementary Figure 3 in Fracassi et al15, we simulated the action of an 
MPC controller on that system and found that whereas oscillations disappered, the time taken to 
reach the set-point was predicted to be approximately 13 hours, thus prompting us to speed up the 
system dynamics in this current study. We carried out a series of set-point control experiments 
(Figure 3) to bring the expression of the fluorescent reporter in the cell population at 50% of its 
maximal value (i.e. stationary expression when no tetracycline is provided to the cells). Achieving 
and maintaining such level using a classical approach would be very difficult, as tetracycline 
concentration would have to be precisely titrated due to the strong nonlinearity of the inducible 
promoter. One syringe is filled with standard growth medium and the other with standard growth 
medium supplemented with tetracycline at a concentration of 100ng/ml plus sulforhodamine to 
track tetracycline concentration. We applied two different MPC strategies (Supporting Information) 
to a set-point control task, one considering a bang-bang control input (i.e. providing either no 
tetracycline or the maximum concentration of tetracycline), the other considering a continuous 
control input (i.e. the controller chooses any tetracycline concentration between 0 and 100ng/ml, 
Supporting Information). The dynamical models used for the implementation of the two MPC 
strategies are reported in Figures S1 and S2. The results of control experiments are shown in Figure 
3, Figure S3 and Movies S1-S4.  Cells reached and maintained the desired fluorescence value 
across the cell population without exhibiting oscillations, vastly improving our previous results 
obtained with Relay and Proportional-Integral controllers15. Interestingly, and as expected from 
optimal control theory, even in the case of continuous control inputs, the MPC algorithm chose as 
the best strategy to achieve the target expression level a bang-bang control input before converging 
to a fixed concentration of about 50ng/ml (Figure 3c,d). It is likely that the actual tetracycline 
concentration in the cell chamber in the case of  a bang-bang control input (Figure 3a,b) is indeed a 
filtered version of the control input because of the delay in the action of the actuator (syrenges and 
diffusion of the medium), effectively making the two strategies (bang-bang and continuos) similar 
at the level of actual tetracycline concentration in the cell chamber, which may explain why the 
performances are so comparable. 
Control of gene expression in mouse Embryonic Stem Cells. To test the generality of our 
approach, we applied automated microfluidics feedback control to regulate gene expression in a 
more complex cell type by means of an alternative inducible system. We engineered mouse 
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Embryonic Stem Cells (mESCs) to express the TET-ON transcriptional transactivator tTA and a 
Degradation Domain (DD) fused mCherry protein from a doxycycline-inducible promoter (Figure 
1b and Supporting Information). In these cells, reporter expression from the inducible promoter is 
only possible in the presence of the tetracycline analog doxycycline (Dox); furthermore, the small-
molecule ligand trimethoprim (TMP) destabilises the protein in a reversible and dose-dependent 
manner, allowing for post-translational control20,21. In the set-point control experiments (Figure 4 
and Movies S5,S6), we successfully applied the MPC strategy with a bang-bang control input to 
regulate the expression of the reporter protein at 50% of its maximal value (Supporting 
Information). The dynamical model used for the implementation of the MPC strategy is reported in 
Figure S4. 
Single-cell control of mTOR signalling pathway activity.  We then applied automated 
microfluidics feedback control to steer the activity of the mTOR pathway in a single cell. It has 
been recently demonstrated that the mTOR pathway controls the activity of the transcription factor 
EB (TFEB), a key player in transcriptional regulation of lysosomal biogenesis and autophagy22,23. 
This control is mediated by mTORC1 phosphorylation of TFEB, the latter being sequestered in the 
cytoplasm. During amino-acid starvation, mTOR signaling is negatively regulated, hence TFEB is 
no longer phosphorylated and it accumulates in the nucleus inducing transcription of its target 
genes24. The nuclear accumulation of TFEB can thus be used as a quantitative biomarker of mTOR 
signalling activity22,25. We generated HeLa cells stably expressing a TFEB-GFP fusion protein from 
a constitutive promoter, in addition to a nuclear mCherry protein to facilitate image analysis (Figure 
1b and Supporting Information).  The variable to be controlled is the nuclear TFEB-GFP 
fluorescence, acting as a quantitative proxy of mTOR activity, whereas the control input is the 
mTOR inhibitor Torin-126 (Figure S5 and Supporting Information). We applied an MPC strategy 
(Supporting Information) considering a bang-bang control input (i.e. providing either no Torin-1 or 
the maximum concentration of Torin-1). All of the experiments start with a calibration phase of 180 
min in the presence of Torin-1 to estimate the maximal TFEB-GFP nuclear fluorescence when 
mTOR signalling is inhibited. We performed single-cell set-point control experiments, to bring 
TFEB-GFP nuclear fluorescence to 50% of its maximum value (Figure 5a,b and Movies S7,S8), as 
well as single-cell signal tracking experiments, where TFEB-GFP nuclear fluorescence must follow 
a time-varying reference (Figure 5c,d and Movies S9,S10).     
Biohybrid oscillator in mouse embryonic stem cells.  Hybrid genetic circuits built by interfacing 
biological systems with virtual in silico counterparts have been recently demonstrated in bacteria17. 
These Bio-Hybrid circuits can be used to quickly test hypotheses on the regulatory logic of gene 
networks and to prototype synthetic circuits. Here, we built a hybrid genetic oscillator in mESC 
expressing a DDmCherry protein from the doxycycline inducible promoter (Figure 1b). The hybrid 
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oscillator, shown in Figure 6a, is based on a delayed negative feedback loop mechanism, where 
cyclic gene expression is mediated by direct, or indirect, repression of the gene promoter by its 
protein product, after a delay that enables protein accumulation27. We ‘virtualised’ the 
transcriptional repression signal so that DDmCherry can inhibit its own expression. This is 
accomplished by implementing a ‘virtual promoter’ in silico by means of the microfluidics platform 
(Figure 6b and Movie S11). At regular sampling times (60 min), mCherry fluorescence in the cell 
population is compared to a threshold level. If fluorescence is below the threshold, the promoter is 
activated by providing Dox+TMP to the cells, otherwise standard medium is provided. We chose 
the threshold to be 50% of the maximum fluorescence when cells are grown in the presence of 
Dox+TMP (Supporting Information). As microscopic images are taken at 60 min intervals, there is 
a minimum 60 min delay between the measurement of mCherry fluorescence and the delivery of the 
input to the cells. However, the effective delay ( in Figure 6a) could be greater as this is affected 
also by DDmCherry transcription, translation and protein stability.  We reasoned that the hybrid 
circuit should be able to generate oscillations because it would act as a delayed negative feedback 
loop. As shown in Figure 6c, periodic oscillations in fluorescence were indeed observed with a 
period of 490 min.  In order to estimate the effective delay from the data, we used a simple 
mathematical model of a delayed negative feedback oscillator (Supporting Information). By fitting 
the model parameters to the data in Figure 6c, we obtained an estimate of the effective delay of 107 
min, which, as expected, is greater than the 60 min sampling delay.  
Discussion 
In this work, we proved the generality and usefulness of the automated microfluidics feedback 
control platform for different applications and experimental testbeds. This technology can be easily 
implemented in any lab without specific training and at very limited costs, as it is based on the Dial-
a-Wave system28, which does not require any dedicated pumps or valve and for which online 
tutorial guides are available (http://biodynamics.ucsd.edu/). 
We have previously described a proof-of-concept approach to control gene expression in a 
microfluidics/microscopy set-up in a mammalian cell line15. Our initial work, however, was limited 
to set-point regulation of gene expression in  single cell-line (CHO) using a rudimentary controller 
(Relay) which was unable to cope with oscillations around the set-point. Here, by means of a 
redesigned microfluidics-based platform, we precisely and robustly control both gene expression 
and endogenous signalling pathway activity in different mammalian cells of biotechnological and 
biomedical interest, including stem cells for the first time, with single-cell precision. We introduced 
a model-based control algorithm, which allowed us to cope with the slow response to inducer 
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molecules preventing oscillations to occur, and an inducer molecule controller, which enable 
precise regulation of its concentration in time. 
We demonstrated that it is possible to precisely regulate gene expression in CHO cells and mouse 
embryonic stems cells (mESCs) from inducible promoters. CHO cells are of extreme 
biotechnological interest and the workhorse in industry for recombinant protein production29. 
Optimisation of the production process, however, requires the ability to accurately control the level 
and timing of gene expression in the host cell factory during the manufacturing process30. The 
automated microfluidics feedback control platform is an enabling technology in this setting and 
could be used for identifying optimal conditions for protein production in continuously perfused 
production processes, or to regulate the level of a protein product that is toxic if highly expressed. 
Our results also pioneer the application of microfluidics-based control of gene expression in mESCs 
and pave the way for more sophisticated control of cellular behaviour in the context of regenerative 
medicine. Indeed, the dynamic expression of pluripotency genes is essential for cell fate 
determination31–36, hence being able to control their dynamics at will provides researchers with 
unprecedented opportunities. 
We also showed that it is possible to dynamically regulate in individual cells the activity of the 
mammalian target of rapamycin (mTOR), a key regulator of cell growth, metabolism and 
proliferation37,38 whose dysregulation often underlies common diseases such as cancer39.  Precise 
control of the mTOR signalling pathway activity will make it possible to quantitatively and 
dynamically study how mTOR regulates downstream biological processes such as autophagy, a key 
pathway of extreme interest for the therapy of neurodegenerative disorders.  
Finally, we showed that our platform can be used to synthetise a hybrid genetic oscillator by 
interfacing biomolecular circuits with virtual in silico components. In the context of synthetic 
biology, bio-hybrid circuits may allow rapid prototyping of synthetic circuits, thus speeding up the 
development phase and hence broadening applicability. 
Our approach is generasible to control other celluler features in addition to gene expression and 
protein localisation, such as cellular morphology.  Indeed, any feature can be used as ‘output’ of the 
biological system to be controlled, as long as there is a molecule or treatment that can be used as 
‘input’ to modify the chosen output.  
Associated Content 
Supporting Information 
Model Identification, control strategies implementation, microscopy and image analysis, cellular 
constructs, microfluidic platform. Movies showing the control experiments.  
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Figures: 
 
Figure 1. Automated microfluidics feedback control platform and cellular models. (a) The 
platform consists of a microfluidic device, a time lapse microscopy and a set of automated syringes, 
all controlled by a computer. Cells grow in a microfluidic device within a temperature- and CO2-
controlled environment under an inverted fluorescence microscope. Images are acquired at regular 
sampling time, and quantification of the fluorescence is performed via an image segmentation 
algorithm. A control algorithm compares the measured fluorescence against the target fluorescence, 
computes the necessary amount and duration of inducer molecule to provide to the cells to achieve 
the target fluorescence and moves the syringes accordingly. (b) Cellular models. CHO-TETOFF 
cell line (top) are Chinese Hamster Ovary cells stable expressing the tetracycline-regulated 
transactivator (tTA) with genomic integration of the tetracycline-repressible promoter (pTRE) 
upstream of destabilised GFP at both mRNA and protein levels (Ubv76GFP) whose expression is 
repressed in presence of tetracycline. Mouse Embryonic Stem Cells mESC-TETON (middle) stably 
expressing the reverse tetracycline-regulated transactivator (rtTA) with genomic integration of the 
tetracycline-inducible pTRE-3G promoter upstream of a destabilised DDmCherry, which is 
expressed in presence of doxycycline; trimethoprim (TMP) allows protein stabilization. HeLa cell 
line (bottom) constitutively expressing the TFEB-GFP fusion protein. TFEB-GFP is phosphorylated 
by mTORC1 and it is cytoplasmic in nutrient-rich medium. mTOR inhibitor Torin-1 induces 
nuclear accumulation of TFEB-GFP.  
 
 13 
 
Figure 2. Implementation of closed-loop feedback control. (a) Block diagram representation of 
the control system. The outer negative feedback loop implements the control of the biological 
system, computing concentration and timing of the inducer molecule (control input) necessary for 
the measured cell fluorescence to become equal to the target reference value.  The inner negative 
feedback loop implements the inducer molecule control, ensuring that the correct concentration of 
inducer molecule (control input) is provided to the cells in the microfluidics device. (b) Actuation is 
provided by two motor-controlled syringes constrained to slide on pulleys and filled with either 
standard growth medium or medium with inducer molecule(s) and fluorescent dye 
(sulforhodamine). (c) In vitro tracking control experiments of inducer molecule concentration (red) 
in a cell chamber of the microfluidic device for two time-varying references (blue). The height of 
the syringes over time is also shown (black line in the lower panels). The average fluorescence in 
the cell chamber is imaged at regular intervals (1 minute). 
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Figure 3. Precise regulation of gene expression from the tetracycline-repressible promoter in 
CHO-TETOFF cells.  Two set-point control experiments are shown using either a fixed 
concentration of tetracycline (a,b) or an arbitrary concentration (c,d) as control input (black line in 
lower panels). The output is the population average fluorescence of UbV76GFP. Control action starts 
at 0 min. Cells are imaged at sampling time of 15 min. The target value of fluorescence (blue line) 
is equal to 50% of the cell fluorescence averaged over the population (here normalised to 1) in the 
absence of tetracycline, during a 180 min calibration phase.  The population average cell 
fluorescence (green line) is shown together with the standard deviation (green shaded area). The 
desired tetracycline concentration (black line) and the actual tetracycline concentration (red line in 
c,d) administered to the cells is shown in the lower panels. 
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Figure 4. Precise regulation of gene expression from the tet-inducible promoter in mouse 
Embryonic Stem Cells (mESC-TETON). (a,b) Set-point control experiments using a fixed 
concentration of Dox+TMP (1000 ng/mL and 100nM respectively) as control input (black line in 
lower panel). The output is the population average fluorescence of DDmCherry. The control action 
starts at 0 min. The target fluorescence value (blue line) is 50% of the cell fluorescence averaged 
over the population (here normalised to 1) in the presence of Dox+TMP during a 120 min 
calibration phase. Cells are imaged at sampling time of 60 minutes.  The population average cell 
fluorescence (red line in the upper panel) and the control input (Dox+TMP concentration) 
administered to the cells are shown (black line in the lower panel). Standard deviation is not shown 
because individual cells could not be resolved by image segmentation algorithm (Supporting 
Information). 
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Figure 5. Single-cell control of mTOR signaling in HeLa TFEB-GFP cells.  Each panel 
represents a control experiment in a single-cell. White arrows indicate the controlled cell after cell 
division has occurred. Two set-point control experiments (a,b) and two reference tracking 
experiments (c,d) are shown. During the 180 min calibration phase at the beginning of each 
experiment, cells are treated with the mTOR inhibitor Torin-1 at the indicated concentrations, 
which induces maximal TFEB-GFP accumulation in the nucleus (green line). Cell nuclei are tagged 
with a mCherry fluorescent protein (red line).  The TFEB-GFP fluorescence is normalised to the 
nuclear mCherry fluorescence. Control action starts at 0 min. A fixed concentration of Torin-1 is 
used as control input (black line). Cell divisions are indicated by grey areas. During cell division 
both mCherry and TFEB-GFP fluorescence increase due to morphological changes of the nucleus. 
(a,b) Set point control experiments. Target fluorescence value (blue line) is 50% of the TFEB-GFP 
nuclear fluorescence reached at the end of calibration phase. (c,d) Tracking control experiments. 
The target fluorescence value in (c) is time-varying and was chosen equal to 50%, 25% and 75% of 
the TFEB-GFP nuclear fluorescence reached at the end of calibration phase. The target fluorescence 
value in (d) is also time-varying and was chosen equal to 50% and 25% of the TFEB-GFP nuclear 
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fluorescence reached at the end of the calibration phase. The longer cell cycle in panel (d) is 
probably caused by Torin-1 treatment. 
 
Figure 6. Bio-Hybrid oscillator in mouse embryonic stem cells. (a) Schematic representation of 
the hybrid synthetic circuit implemented in mESCs expressing DDmCherry from the tetracycline-
inducible promoter (Figure 1b). DDmCherry represses its own transcription, after a delay , thanks 
to a ‘virtual’ transcriptional regulation (dashed line) implemented in silico via the microfluidics 
platform. (b) Transcriptional regulation is achieved by a ‘virtual’ DDmCherry responsive promoter 
driving mCherry expression. If mCherry fluorescence at time ti is higher than 0.5 normalised units. 
then a time ti + T the promoter is repressed (i.e. standard medium is provided to the cells), where 
the sampling T=60 min. Vice-versa, the promoter is maximally activated (i.e. Dox+TMP is 
provided to the cells) if mCherry fluorescence at time ti is lower than 0.5 normalised units. (c) 
Population average mCherry fluorescence (red line) produced by the Bio-Hybrid oscillator in 
mESCs.  Doxycycline concentration over time is also shown (black line). Standard deviation is not 
shown because individual mESCs could not be resolved by image segmentation algorithm (Online 
Methods). 
 
 
 
 
 
 
 
